1/9/2026

Janusmed fosterpåverkan

Janusmed fosterpåverkan – triamcinolonhexacetonid

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Triamcinolon – för hud och slemhinnor

Triamcinolon – för hud och slemhinnor

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Dhar S, Seth J, Parikh D. Systemic side-effects of topical corticosteroids. Indian J Dermatol. 2014;59(5):460-4.

  2. Chi CC, Wang SH, Wojnarowska F, Kirtschig G, Davies E, Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015;10:CD007346.

  3. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197(6):585e1-7; discussion 683-4, e1-7.

  4. Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011;183(7):796-804.

  5. Edwards MJ, Agho K, Attia J, Diaz P, Hayes T, Illingworth A et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet 2003;120A:459-63.

  6. Mygind H, Thulstrup AM, Pedersen L, Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand 2002;81:234-9.

  7. Skuladottir H, Wilcox AJ, Ma C, Lammer EJ, Rasmussen SA, Werler MM et al. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014;100(6):499-506.

  8. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology 1997;56:335-40.

  9. APL. Triamcinolon APL 0,1 % Munhålegel Produktmonografi. AIDA APL [www]. [updated 2016-03-15, cited 2025-12-16].

  10. Läkemedelsverket. Pevisone Produktresumé. Läkemedelsverket [www]. [updated 2023-05-26, cited 2025-12-16].

  11. Ramadas AA, Jose R, Arathy SL, Kurup S, Chandy ML, Kumar SP. Systemic absorption of 01% triamcinolone acetonide as topical application in management of oral lichen planus. Indian J Dent Res. 2016;27(3):230-5.

  12. Katz VL, Thorp JM, Bowes WA. Severe symmetric intrauterine growth retardation associated with the topical use of triamcinolone. Am J Obstet Gynecol. 1990;162(2):396-7.

  1. Dhar S, Seth J, Parikh D. Systemic side-effects of topical corticosteroids. Indian J Dermatol. 2014;59(5):460-4.
  2. Chi CC, Wang SH, Wojnarowska F, Kirtschig G, Davies E, Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015;10:CD007346.
  3. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197(6):585e1-7; discussion 683-4, e1-7.
  4. Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011;183(7):796-804.
  5. Edwards MJ, Agho K, Attia J, Diaz P, Hayes T, Illingworth A et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet 2003;120A:459-63.
  6. Mygind H, Thulstrup AM, Pedersen L, Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand 2002;81:234-9.
  7. Skuladottir H, Wilcox AJ, Ma C, Lammer EJ, Rasmussen SA, Werler MM et al. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014;100(6):499-506.
  8. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology 1997;56:335-40.
  9. APL. Triamcinolon APL 0,1 % Munhålegel Produktmonografi. AIDA APL [www]. [updated 2016-03-15, cited 2025-12-16].
  10. Läkemedelsverket. Pevisone Produktresumé. Läkemedelsverket [www]. [updated 2023-05-26, cited 2025-12-16].
  11. Ramadas AA, Jose R, Arathy SL, Kurup S, Chandy ML, Kumar SP. Systemic absorption of 01% triamcinolone acetonide as topical application in management of oral lichen planus. Indian J Dent Res. 2016;27(3):230-5.
  12. Katz VL, Thorp JM, Bowes WA. Severe symmetric intrauterine growth retardation associated with the topical use of triamcinolone. Am J Obstet Gynecol. 1990;162(2):396-7.
1 1
1 1

Triamcinolon – intranasalt

Triamcinolon – intranasalt

Klass : 1

Visa all info

Skriv ut

Kontakta oss

      2 2
      2 2

      Triamcinolon – för injektion

      Triamcinolon – för injektion

      Klass : 2

      Visa all info

      Skriv ut

      Kontakta oss

      1. UK Teratology Information Service (UKTIS). USE OF SYSTEMIC CORTICOSTEROIDS IN PREGNANCY. UKTIS [www]. [updated 2023-07-01, cited 2025-12-17].

      2. Jølving LR, Nielsen J, Andersen ML, Friedman S, Nørgård BM. Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study. BMC Med. 2023;21(1):140.

      3. Bay Bjørn AM, Ehrenstein V, Hundborg HH, Nohr EA, Sørensen HT, Nørgaard M. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther. 2014;21(2):73-80.

      4. Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011;183(7):796-804.

      5. Xiao WL, Liu XY, Liu YS, Zhang DZ, Xue LF. The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis. Reprod Toxicol. 2017;69:99-105.

      6. Reprotox. Prednisolone. Micromedex [www]. [cited 2023-02-08].

      7. Hellgren K, Secher AE, Glintborg B, Rom AL, Gudbjornsson B, Michelsen B et al. Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark. Rheumatology (Oxford). 2022;61(9):3711-3722.

      8. Rikshandboken i barnhälsovård. Vägledning för vaccination med levande försvagade vaccin, av barn som under graviditeten eller vid amning exponerats för immunmodulerande läkemedel. Rikshandboken i barnhälsovård [www]. [updated 2022-09-26, cited 2025-12-17].

      9. Burton PJ, Waddell BJ. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Biol Reprod. 1999;60(2):234-40.

      10. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr. 1972;81(5):936-45.

      11. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol. 1977;127(3):264-7.

      12. Läkemedelsverket. Kenacort-T Produktresumé. Läkemedelsverket [www]. [updated 2025-11-28, cited 2025-12-18].

      13. Läkemedelsverket. Lederspan Produktresumé. Läkemedelsverket [www]. [updated 2025-01-29, cited 2025-12-18].

      14. Sidhu G, Preuss CV. Triamcinolone. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025

      15. Turan SA, Yıldırım AA, Bütün Z, Kayapınar M, Turan H. The Experience of Pain Management for Pregnancy-Related Musculoskeletal Pain: A Retrospective Cohort Analysis. Istanbul Med J. 2025;26(1):57-63.

      16. Filippini C, Saran S, Chari B. Musculoskeletal steroid injections in pregnancy: a review. Skeletal Radiol. 2023;52(8):1465-1473.

      1. UK Teratology Information Service (UKTIS). USE OF SYSTEMIC CORTICOSTEROIDS IN PREGNANCY. UKTIS [www]. [updated 2023-07-01, cited 2025-12-17].
      2. Jølving LR, Nielsen J, Andersen ML, Friedman S, Nørgård BM. Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study. BMC Med. 2023;21(1):140.
      3. Bay Bjørn AM, Ehrenstein V, Hundborg HH, Nohr EA, Sørensen HT, Nørgaard M. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther. 2014;21(2):73-80.
      4. Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011;183(7):796-804.
      5. Xiao WL, Liu XY, Liu YS, Zhang DZ, Xue LF. The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis. Reprod Toxicol. 2017;69:99-105.
      6. Reprotox. Prednisolone. Micromedex [www]. [cited 2023-02-08].
      7. Hellgren K, Secher AE, Glintborg B, Rom AL, Gudbjornsson B, Michelsen B et al. Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark. Rheumatology (Oxford). 2022;61(9):3711-3722.
      8. Rikshandboken i barnhälsovård. Vägledning för vaccination med levande försvagade vaccin, av barn som under graviditeten eller vid amning exponerats för immunmodulerande läkemedel. Rikshandboken i barnhälsovård [www]. [updated 2022-09-26, cited 2025-12-17].
      9. Burton PJ, Waddell BJ. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Biol Reprod. 1999;60(2):234-40.
      10. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr. 1972;81(5):936-45.
      11. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol. 1977;127(3):264-7.
      12. Läkemedelsverket. Kenacort-T Produktresumé. Läkemedelsverket [www]. [updated 2025-11-28, cited 2025-12-18].
      13. Läkemedelsverket. Lederspan Produktresumé. Läkemedelsverket [www]. [updated 2025-01-29, cited 2025-12-18].
      14. Sidhu G, Preuss CV. Triamcinolone. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025
      15. Turan SA, Yıldırım AA, Bütün Z, Kayapınar M, Turan H. The Experience of Pain Management for Pregnancy-Related Musculoskeletal Pain: A Retrospective Cohort Analysis. Istanbul Med J. 2025;26(1):57-63.
      16. Filippini C, Saran S, Chari B. Musculoskeletal steroid injections in pregnancy: a review. Skeletal Radiol. 2023;52(8):1465-1473.